$399/mo — what that covers, line by line.
From Willow's own published pages, checked October 2026. Terms change, so confirm them with Willow before you enrol.
Here's how Willow rates on each part of the Selene Care Standard. The two that matter most — PMOS (PCOS) fit and Endo-aware care — get a single star (full, half, or empty). The five care basics get a simple check. Price is shown but never part of the rating.
Willow sits at the top of the price range here, listing compounded tirzepatide at $399 a month, and its FAQ notes that medication costs vary by dosage — so treat the figure as the starting point rather than a guaranteed monthly total.
What the money buys is dosing craft. Custom 503A doses titrated upward from a deliberately sub-therapeutic start is the gentlest approach available here, and for anyone who has stopped a medication because the steps were too big, that is the argument.
No PMOS (PCOS) or insulin-resistance focus.
No hormonal or endo context offered.
Custom 503A doses titrated up from a sub-therapeutic start to fit your response.
24/7 Care Team support and unlimited doctor messaging.
Positioned as a medication provider; no maintenance or taper built in.
$399/mo listed with no commitment, no additional fees and cancel-anytime terms, but the FAQ notes medication costs vary by dosage without listing them.
Peer community access; a coaching programme is not listed on their site.
Beginning below a therapeutic dose and building up gives your system time to adapt, and custom 503A preparation means the increments are made for you rather than chosen from a menu. Cancellation is straightforward: message the care team at least two business days before the next order is processed, with a full refund if you stop before the prescription reaches the pharmacy, and the FAQ lists no additional fees.
Willow is positioned as a medication provider, with no maintenance or taper built in and no coaching programme listed, though members get peer community access. Support is a 24/7 Care Team with unlimited doctor messaging. There is no PMOS or endo context anywhere in the model.
Send these to Willow and keep the answers.
Willow does one thing genuinely well at the top price and makes leaving simple. It sits in the lower half of this Standard because it attempts none of the condition-specific care the Standard measures — and it says as much itself. The missing coaching and taper are the real trade at this price.
This reflects what Willow publishes, and providers revise terms without announcing it, so treat it as a starting point and confirm the details yourself. Selene is editorial, no provider pays to appear or to rank here, and nothing here is medical advice. GLP-1 medications are not a treatment for endometriosis.